HCPCS code P9057 – Red blood cells, frozen/deglycerolized/washed

Found our content helpful?

Key takeaways

HCPCS Code P9057 describes red blood cells that are frozen, deglycerolized, washed, leukocyte-reduced, and irradiated, billed as each unit.

Five processing steps sit inside one code: freezing, deglycerolization, washing, leukoreduction, and irradiation. Billing a less-processed code such as P9056 when all five apply is the most common error.

P9057 is used for immunocompromised patients, transplant recipients, and people with rare blood types who need the most modified red cell product available.

Practice management software like Pabau keeps the code, the documentation, and the invoice on one record, so billing errors surface before submission.

P9057 code details at a glance

P9057 sits within the P-series of HCPCS Level II, which CMS designates for blood and blood products (P9010-P9100). The table below captures the key administrative metadata for quick reference.

What the five processing steps mean

Each term in the P9057 descriptor represents a distinct laboratory step. Coders unfamiliar with transfusion medicine often undercode because they cannot tell which steps were performed. Only P9057 applies when all five appear in the transfusion record.

• Freezing (cryopreservation): RBCs are stored at ultra-low temperatures, typically with glycerol as a cryoprotectant. This enables long-term storage of rare blood types, sometimes for years.
• Deglycerolization: After thawing, the glycerol cryoprotectant must be removed through a washing process. The blood bank record must state this step explicitly, because it separates P9057 from codes for simply washed or simply frozen cells.
• Washing: A further wash step removes residual plasma proteins, white cell debris, and other non-RBC components. This reduces the risk of allergic transfusion reactions.
• Leukoreduction (leukocytes reduced): White blood cells are filtered out. According to the AABB Technical Manual, leukoreduction reduces febrile non-hemolytic transfusion reactions and lowers the risk of cytomegalovirus (CMV) transmission.
• Irradiation: Gamma or X-ray irradiation inactivates residual T-lymphocytes. As the AABB and FDA guidance on irradiated blood confirm, this step prevents transfusion-associated graft-versus-host disease (TA-GvHD) in susceptible patients.

All five steps must be documented in the patient’s transfusion record and the facility’s blood bank records to support the P9057 claim. Missing documentation for any single step can result in a claim denial or a downcode to a less-processed product code.

Clinical indications: When is P9057 ordered?

This product exists because certain patient populations cannot safely receive standard blood products. The combination of leukoreduction and irradiation makes P9057 appropriate for the highest-risk transfusion scenarios.

• Immunocompromised patients: Hematologic malignancy patients (leukemia, lymphoma), bone marrow transplant recipients, and solid organ transplant recipients are the primary population. Their suppressed immune systems cannot reject donor T-lymphocytes, which makes TA-GvHD a risk without irradiation.
• Intrauterine and neonatal transfusions: Fetuses and premature neonates receive irradiated products due to immune system immaturity.
• Rare blood type inventory: Patients with alloantibodies or rare phenotypes may only have compatible units in the frozen rare blood bank. That inventory makes the freeze, deglycerolize and wash steps unavoidable.
• Congenital immunodeficiency disorders: Patients with severe combined immunodeficiency (SCID) or DiGeorge syndrome require irradiated components.
• Directed donations from blood relatives: Family donor blood carries a higher TA-GvHD risk because of HLA similarities. Irradiation is typically required.

Clinical necessity criteria for irradiation and leukoreduction are set by treating physicians and institutional transfusion protocols, not by billing staff.

The coder’s role is to confirm the documentation reflects the product’s processing, then match that to P9057. Retaining the supporting transfusion records is what defends the claim in an audit.

Medicare and Medicaid billing guidelines for P9057

HCPCS Code P9057 is reimbursed by Medicare and Medicaid as an outpatient hospital blood product. Several billing rules govern how the claim is structured and what documentation is required. Submit one unit of P9057 per processed unit transfused, and never aggregate multiple units into one line item.

Never state a specific dollar reimbursement rate without checking the current CMS fee schedule. Rates change annually with the Outpatient Prospective Payment System (OPPS) update. Mapping each HCPCS code to the right payer rule by hand is slow. Many facilities hand that step to software for billing teams.

ICD-10 diagnosis codes commonly billed with P9057

P9057 requires a supporting diagnosis code on the claim. Payer policies differ on which ICD-10-CM codes they treat as medically necessary for this product.

The table below lists the diagnosis codes most commonly paired with P9057 in transfusion medicine billing. Confirm payer-specific requirements before submitting, because not all payers accept every code listed here without prior authorization.

Related HCPCS blood product codes

Miscoding between adjacent P-series codes is one of the most common errors in blood product billing. The table below shows where HCPCS Code P9057 sits relative to its nearest neighbors. Select the code that reflects the processing steps documented in the blood bank record.

Use the AAPC HCPCS code lookup to verify current code descriptors before billing, since CMS updates effective dates and descriptor language annually. If the unit transfused was platelets rather than red cells, P9033 is the code to check.

Common billing errors and how to avoid them

Blood product billing carries a high denial risk when the documentation and the coded product disagree. Every error below comes down to one question. Which processing steps does the blood bank record document? The matrix answers that for the five codes coders confuse most often.

• Using P9056 instead of P9057: P9056 covers irradiated whole blood, not processed RBCs. If the blood bank record shows separated red cells that went through the full freeze-thaw-deglycerolization cycle, P9056 is the wrong code. The two product types are clinically and financially distinct.
• Billing P9016 or P9058 when all five steps apply: P9016 covers leukoreduced RBCs without irradiation. P9058 adds a CMV-negative specification but omits the freeze-thaw cycle. If the transfused unit was frozen, deglycerolized, washed, leukoreduced, AND irradiated, use P9057.
• Unbundling processing steps: HCPCS Code P9057 is an all-inclusive code. Do not bill separate freezing or thawing CPT codes alongside it, because those charges belong in the P9057 charge. CPT 86945 for irradiating a blood product applies only when no HCPCS code already covers the irradiated product.
• Billing per transfusion episode rather than per unit: P9057 is billed “each unit.” If a patient receives two units in one session, bill two units of P9057. Follow your payer’s instruction on whether that is two lines of quantity 1 or one line of quantity 2.
• Missing blood bank processing documentation: A physician order for irradiated products is necessary but not sufficient. The blood bank’s processing record must confirm each step explicitly. Facilities need a documentation protocol that their blood bank and billing teams both work from.

Pre-billing review catches these before a remittance advice does. Working through the denial codes that recur on blood product claims will show you which documentation step keeps failing.

Outpatient hospital vs. physician office billing context

HCPCS Code P9057 is primarily structured for outpatient facility billing. Payer policies from Molina Healthcare and UnitedHealthcare, for example, frame their blood product coverage under “Outpatient Hospital Blood and Blood Products Policy (Facility).” That framing decides where the code can be applied.

• Outpatient hospital (facility billing): The standard and expected setting for P9057. The facility submits the blood product code on the facility claim (UB-04) alongside the transfusion administration CPT code.
• Physician office: HCPCS blood product codes are generally not billable in the physician office setting for Medicare outpatient facility rates. If a physician-administered transfusion occurs in an office, confirm Medicare’s applicable billing pathway first.
• Inpatient setting: Blood product costs are typically bundled into the MS-DRG payment for inpatient Medicare admissions. P9057 would not normally appear as a separately billed line item on an inpatient claim.

The NLM Clinical Table Search API provides programmatic access to HCPCS Level II code descriptors for facilities building automated billing workflows.

How Pabau keeps the coding evidence on one record

In most facilities the blood bank record, the physician order, and the claim live in three systems. A biller reads the processing record, picks the code by hand, and hopes the two still match at audit.

Practice management software like Pabau keeps the clinical record, the documentation, and the invoice on one patient file. The coded charge sits next to the note that supports it. A reviewer checking a P9057 line has the evidence on the same record.

Reporting then shows which codes get paid and which keep coming back. When P9057 lines are being downcoded, you see the pattern in a report rather than in next quarter’s revenue.

Keep the coding evidence on one record

Pabau keeps clinical documentation, coded charges, and invoices on one patient record, so billing teams can evidence a claim without switching systems. See how that reduces rework on complex blood product codes.

Book a demo

Conclusion

P9057 is one of the most specific codes in the P-series, and that specificity is the whole job. The code is right only when the blood bank record shows all five processing steps, and wrong the moment one is missing.

So the work that pays off sits upstream of the claim. Get the blood bank and the billing team onto one documentation protocol, and the code choice stops being a judgment call. Audit the P-series lines quarterly, and downcoding shows up while you can still appeal it.

Book a demo to see how Pabau keeps clinical documentation and coded charges on the same patient record.

Continue your research

Need to understand how clearinghouse submissions work for facility claims? How a medical claims clearinghouse works explains the submission pathway from facility billing to payer adjudication.

Seeing recurring denials on blood product claims? Reading electronic remittance advice (ERA) walks through how to interpret 835 remittance files and identify denial patterns at the CARC/RARC level.

Building a documentation protocol for complex HCPCS products? Revenue cycle management fundamentals covers how documentation, coding, and billing connect across the claim lifecycle.

Frequently asked questions